SHINE Gains EU Approval for Lu-177 Radioisotope Ilumira
European marketing authorization allows SHINE to distribute lutetium-177 for targeted radioligand therapies across the EU. SHINE Technologies has received centralised marketing authorization from the European Union for Ilumira, its non-carrier-added lutetium-177 (Lu-177) r